At the start of the year, the storm clouds of anti-tobacco harm reduction (THR) were darkening, threatening as ever the lives of smokers looking to switch or stop. But in the bleak mid-winter, rays of reason have shone a light on those that needed to be called to account.Read More
IJERPH is now accepting submissions for a special issue on Tobacco Harm Reduction, on research that advances our understanding of the potential place of tobacco harm reduction strategies within a comprehensive approach to reducing the burden of smoking related disease, and that will assist policy makers to determine what level of regulation is most appropriate for potential reduced risk products.
The annual Vapril campaign to help smokers switch to vaping launched yesterday (1 April). The digitally-focused 2020 campaign seeks to address consumer “misinformation” about vaping with “evidence-backed advice and information”. It follows last month’s evidence update on the UK e-cigarette market by Public Health England (PHE) which revealed that 37% of smokers had never tried vaping and that over half of them wrongly believed it to be equally or more harmful than smoking. PHE continues to highlight that regulated nicotine vaping is at least 95% less harmful than conventional smoking.
As new data and studies are emerging on the SARS-CoV-2, we will be constantly upgrading technical information. The present upgrade incorporates information on (1) more recent misinformation (Bloomberg News), (2) new data on COVID-19 vs smoking and (3) more information on environmental vapor
That's particularly concerning for the more than 1 billion smokers worldwide who are at higher risk of a getting a serious case of COVID-19. After months or years of a nicotine habit, quitting now may not help a smoker's odds when it comes to the present danger. And yet, the crisis is serving as a wake-up call for many to pay better attention to their health. As a result, smoking cessation startups are among the healthcare companies seeing their business improve since the outbreak started. [...]
[...] Less than two hours before Trump took to the podium, Jerome Adams was speaking to a sparsely attended room at the Society for Research on Tobacco and Nicotine's (SRNT) annual conference. SRNT is one of the biggest tobacco control conferences in the world. Academics, government officials, and nonprofits share research and ideas, mostly on how to regulate or ban nicotine products. A majority of registrants failed to show up, citing fears of contracting or spreading COVID-19. But Adams was clear: Even amid a global pandemic, regulating tobacco can't be ignored.
At the start of the year, the storm clouds of anti-tobacco harm reduction (THR) were darkening, threatening as ever the lives of smokers looking to switch or stop. But in the bleak mid-winter, rays of reason have shone a light on those that needed to be called to account.
Over half a billion smokers live in Asia, and Asian countries have some of the highest per capita smoking rates – and some of the highest numbers of smoking-related deaths – in the world.
Given the staggering damage to its citizens’ health that smoking is responsible for you’d think that regional governments would be eagerly embracing any less harmful alternatives such as vapes and heat-not-burn (HNB) devices to encourage people to wean themselves off conventional tobacco
Keeping up to date with the proceedings of the World Conference on Tobacco or Health, in Cape
We aim to bring our readers updates that reflect the wide range of views, debates and discussions currently taking place on nicotine science and policy. Please note that inclusion of an article in our list does not demonstrate endorsement of the contents.
EU e-Privacy Directive